AGEN
AGENUS INC
+0.01 (+0.14%)7.22USD214K成交股數325M市值2.4本益比(近四季)2.5股價營收比+34.4%營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 34.5M+43% | 33.7M+26% | 30.2M+20% | 25.7M+9% | 24.1M-14% | 26.8M+10% | 25.1M-1% | 23.5M+3% | 28.0M | 24.3M | 25.3M | 22.9M |
| 營業成本 | 0.00 | 0.00 | 642K | 243K | 137K | 118K | 146K | 115K | 107K | 303K | 254K | 2.3M |
| 毛利 | 34.5M+44% | 33.7M+26% | 29.6M+19% | 25.4M+9% | 23.9M-14% | 26.7M+11% | 25.0M-0% | 23.4M+14% | 27.9M | 24.0M | 25.0M | 20.6M |
| 毛利率 | 100.0% | 100.0% | 97.9% | 99.1% | 99.4% | 99.6% | 99.4% | 99.5% | 99.6% | 98.8% | 99.0% | 90.0% |
| 研發費用 | 14.8M | 11.8M | 23.6M | 26.7M | 21.5M | 33.8M | 41.1M | 36.8M | 43.9M | 51.4M | 59.3M | 57.1M |
| 銷售管理費用 | 8.5M | 6.9M | 10.9M | 15.5M | 15.7M | 20.9M | 17.3M | 16.8M | 16.9M | 18.9M | 20.4M | 18.2M |
| 營業利益 | 11.3M-185% | 15.1M-158% | −4.5M-86% | −16.7M-45% | −13.3M-60% | −25.9M-44% | −31.5M-42% | −30.2M-44% | −32.9M | −46.3M | −54.7M | −54.3M |
| 營業利益率 | 32.7% | 44.6% | -15.0% | -65.0% | -55.3% | -96.5% | -125.5% | -128.4% | -117.4% | -190.6% | -216.1% | -237.3% |
| 稅後淨利 | −567K-98% | 39.2M-184% | 63.9M-195% | −30.0M-45% | −26.4M-58% | −46.8M-27% | −67.2M-8% | −54.8M-23% | −63.5M | −64.5M | −73.4M | −70.9M |
| 淨利率 | -1.6% | 116.2% | 211.4% | -116.8% | -109.6% | -174.4% | -267.7% | -233.1% | -226.6% | -265.4% | -290.3% | -309.5% |
| 稀釋 EPS | -0.01-99% | 1.02-152% | 1.94-163% | -1.00-60% | -1.03-66% | -1.95-41% | -3.08-22% | -2.52-42% | -3.04 | -3.29 | -3.93 | -4.31 |
| 稀釋股數 | 41.3M | 38.3M | 32.9M | 28.1M | 24.5M | 21.5M | 21.6M | 21.1M | 20.4M | 18.9M | 17.6M | 15.9M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 18.7M | 35.0M | 3.5M | 9.5M | 18.5M | 40.4M | 44.8M | 93.7M | 52.9M | 106M | 143M | 165M |
| 應收帳款 | 14.7M | 6.6M | 538K | 709K | 354K | 407K | 207K | 719K | 476K | 1.0M | 1.3M | 1.4M |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 173M | 186M | 234M | 185M | 200M | 226M | 238M | 292M | 257M | 335M | 384M | 413M |
| 有息負債 | 30.1M | 30.2M | 23.6M | 23.2M | 32.8M | 30.5M | 0.00 | 0.00 | 0.00 | 12.7M | 12.7M | 12.6M |
| 總負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 股東權益 | −199M | −221M | −274M | −355M | −342M | −326M | −292M | −241M | −201M | −129M | −93.2M | −58.5M |
| 負債比 | – | – | – | – | – | – | – | – | – | – | – | – |
| 淨現金(現金 − 有息負債) | −11.3M | 4.8M | −20.1M | −13.6M | −14.4M | 10.0M | 44.8M | 93.7M | 52.9M | 93.6M | 131M | 152M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −36.0M | – | – | −25.6M-33% | – | – | – | −38.2M | – | – | −58.5M |
| 資本支出 | – | 0.00 | – | – | 5K | – | – | – | 35K | – | – | 1.8M |
| 自由現金流 | – | −36.0M | – | – | −25.6M-33% | – | – | – | −38.2M | – | – | −60.4M |
| 折舊攤銷 | – | 583K | – | – | 3.2M | – | – | – | 3.4M | – | – | 2.6M |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -106.6% | – | – | -106.5% | – | – | – | -136.5% | – | – | -263.6% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
地區2025 年度 · 114M
| 美國 | 113M | 99.1% | +11.5% |
|---|---|---|---|
| 美國以外 | 1.0M | 0.9% | -48.3% |
產品／服務2025 年度 · 224M
| Non Cash Revenue Related To Sale Of Future Royalties | 109M | 48.4% | +7.5% |
|---|---|---|---|
| Non Cash Royalty Revenue | 109M | 48.4% | +7.5% |
| Pre Commercial Product Revenue | 4.2M | 1.9% | – |
| 其他 | 1.0M | 0.5% | -48.3% |
| Revenue | 1.0M | 0.5% | -48.3% |
| Clinical Product Revenue | 334K | 0.1% | -30.7% |
| Research And Development Revenue | 334K | 0.1% | -30.7% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 114M | +10.4% | −3.1M | -2.7% | 0.00 | −77.2M |
| FY2024 | 103M | -33.8% | −232M | -224.5% | -10.59 | −159M |
| FY2023 | 156M | +59.5% | −257M | -164.7% | -13.75 | −234M |
| FY2022 | 98.0M | -66.8% | −231M | -235.3% | -15.64 | −228M |
| FY2021 | 296M | +235.3% | −28.7M | -9.7% | -0.11 | −23.7M |
| FY2020 | 88.2M | -41.2% | −183M | -207.4% | -1.05 | −143M |
| FY2019 | 150M | +307.9% | −112M | -74.3% | -0.80 | −23.3M |
| FY2018 | 36.8M | – | −162M | -440.5% | -1.44 | −135M |